The Effect of Aromatherapy With Lavender Essential Oil on the Sleep and Fatigue Level of Patients With Multiple Sclerosis: A Randomized Controlled Trial

Status unknownNot a drug-phase studyMS (type not specified)NCT05929638

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • lavender oil

What it measured

Main measures

  • Fatigue Severity Scale -FSS

    two week

    Fatigue
  • Pittsburgh Sleep Quality Index (PUKI)

    Two week

    Myelin repairMood and sleep

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Being 18 years or older, * Having been diagnosed with MS at least 1 year ago, * Verbal communication (hearing and speaking) * No problem with sense of smell, * Not having an allergy to lavender, * Having fatigue and sleep problems for the last 3 months, * Not applying an intervention that helps to fall asleep, * Pittsburgh Sleep Quality Index ≥5, * Fatigue Severity Scale ≥4.

Exclusion criteria

* Having had an attack in the last month, * Having DSM-IV Axis I disorder, * Pregnancy, * Using sleeping pills, * Breastfeeding

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The study was conducted with patients with Multiple Sclerosis (MS) who applied to the Neurology Outpatient Clinic of Atatürk University Research Hospital, met the inclusion criteria and agreed to participate in the study. At the time of the study, 96 patients were interviewed. 26 patients were excluded from the study because they did not meet the research criteria, and 70 multiple sclerosis patients constituted the research sample. 1 person from the control group and 1 person from the experimental group did not continue to work and 1 person developed a lavender allergy. The study was completed with 63 multiple sclerosis patients.

Loading reviews and guidelines…

History

    1. Started

      Jan 2023

    2. Main results due

      May 2023

    3. Finished

      Jul 2023

    Assembled by software from public sources.